Open AccessMP41-19 ADVERSE EVENTS OF THE SECOND-LINE TREATMENT STRATEGIES FOR PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA OF THE BLADDER: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Author(s) -
Ekaterina Laukhtina,
Keiichiro Mori,
Hadi Mostafaei,
Axel S. Merseburger,
Péter Nyírády,
Marco Moschini,
Fahad Quhal,
Benjamin Pradère,
Reza Sari Motlagh,
Victor M. Schuettfort,
Dmitry Enikeev,
Shahrokh F. Shariat
Publication year - 2021
Publication title -
the journal of urology/the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1097/ju.0000000000002062.19
Subject(s) - medicine , meta analysis , randomized controlled trial , discontinuation , adverse effect , metastatic urothelial carcinoma , bladder cancer , systematic review , oncology , urothelial carcinoma , medline , cancer , political science , law